patent
Surge in filings for UK pharma and biotech patents many be a sign of growing investor confidence, say IP experts
A surge in pharma and biotech patents in the UK, reported by the European Patent Office (EPO), may be a sign of growing investor confidence within these sectors, according to IP firm Marks & Clerk. more
US patent secured for smartphone diagnostic technology
Novarum, wholly owned subsidiary of BBI Solutions, has been secured a US patent for its smartphone diagnostic technology. more
US patent awarded to cloud-based R&D software provider, Riffyn
Cloud-based R&D software provider, Riffyn, has been granted a patent on a hypergraph data model for experiment design and data analysis by the US Patent Office. more
![Legal money]](https://www.epmmagazine.com/downloads/5762/download/Legal.gif?cb=d11900ebb180818aeb8c0f970a7d625f&w={width}&h={height})
Pfizer’s unsuccessful patent appeal may mean the NHS can recoup £502 million, according to new article
Researchers from the University of Oxford in collaboration with an intellectual property law firm have revealed that the NHS may be able to recoup over half a billion pounds from Pfizer if its Supreme Court patent appeal is unsuccessful more
BioAxial receives US patent covering its ‘black fluorophore’ tech
BioAxial, a developer and seller of Conical Diffraction Microscopy (CODIM) technology, has been granted a US patent covering ‘black fluorophore’ technology, which will be included in the second generation of CODIM products. more
BIA is granted permission to intervene in Supreme Court case
The UK Bioindustry Association (BIA) has been allowed to intervene in a Supreme Court case, reviewing Warner-Lambert Company LLC v Generics (UK) Ltd and Actavis. more
Pluristem granted key US patent for use of stem cells for muscle regeneration
Developer of placenta-based cell therapy products, Pluristem, has been granted a key US patent by the US Patent and Trademark Office (USPTO) relating to the use of Mesenchymal Stem Cells (MSCs) for muscle regeneration. more
Patent granted to CAP-Go technology for recombinant glycoproteins
CEVEC Pharmaceuticals has been granted a patent for its expression technology CAP-Go, strengthening the company’s position in producing recombinant proteins with tailor-made glycosylation. more
Breathe easily: Pulmatrix receives patents for its inhaled drug delivery tech and COPD drug
Clinical stage biopharmaceutical company, Pulmatrix, has received two key patents from the US Patent and Trademark Office for its inhaled drug delivery platform and its most advanced drug candidate for chronic obstructive pulmonary disease (COPD) more
The biotech revolution: Risks and opportunities of the growing trend
Recently, there has been a shift within the pharmaceutical industry veering its R&D away from the traditional corporate campuses and moving them to new collaborative biotech clusters. Nick Sutcliffe, discusses the risks and opportunities of the trend more
Codexis is awarded summary judgement in patent infringement lawsuit
Protein engineering company, Codexis, has obtained a court order awarding a summary judgement of 10 claims of patent infringement against EnzymeWorks. more
Full judgment on patent infringement case, found in favour of Lilly
The UK Supreme Court (UKSC) has released its full judgment on the long running court case involving the product infringement of Eli Lilly and Company’s Alimta vitamin regimen patent — Actavis v Eli Lilly Case. more
Indian patent infringement case results in win for DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals (DSP) has announced that the High Court of Delhi has granted a permanent injunction against Sinopharm Weiqida Pharmaceutical for patent infringement in India. more
RedHill receives allowance for two new patents
Speciality biopharmaceutical company, RedHill Biopharma, has received notices of allowance from the US Patent and Trademark Office (USPTO) for two new patents covering BEKINDA (RHB-102). more
Trials and tribulations: Protecting pharma IP
What role will IP management play in protecting pharmaceutical companies in the future? Casey Fowler, VP of IP Search, CPA Global writes. more
Patent wars: Branded drugs vs generic counterparts
Isobel Finnie, partner at European intellectual property firm Haseltine Lake, alongside associate Catherine Williamson, discuss the growing patent battle between pharmaceutical branded drugs and their cheaper, generic counterparts. more
Merck and Ionis Pharma awarded $200m in patent infringement battle
Gilead Sciences is to pay $200m for infringing upon Merck and Ionis Pharmaceuticals’ Hepatitis C drug patents more
Amgen wins patent battle against Sanofi and Regeneron
A US district court jury have ruled that the asserted claims of two Amgen patents for antibodies targeting PCSK9 are valid, yet Sanofi and Regeneron Pharmaceuticals have announced that they disagree with the verdict more
EPM’s most read stories of February 2016
With Valentines Day over and Easter fast-approaching, the second month of the year is already drawing to a close. We take a look at our most read stories from the last month. Two down and ten more to go… more
AstraZeneca patent expiration forecasts earnings drop
AstraZeneca’s patent on its anti-cholesterol drug, Crestor, is due to expire in May this year and with that expiration could come a drop in the company’s profits more
